Identification of nonresponsive isolates to glucantime in patients with cutaneous leishmanaisis in Bam

Journal of Kerman University of Medical Sciences

Volumn 18, Issue 2, 2011, Pages

  Pour, R ^a   Sharifi, I ^a   Kazemi, B ^b   Zarean, M ^a  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bam; Cutaneous leishmaniasis; Drug resistance; Leishmania tropica; Nested PCR

Indexed keywords

MEGLUMINE ANTIMONATE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HUMAN; IRAN; LEISHMANIA MAJOR; LEISHMANIA TROPICA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NESTED POLYMERASE CHAIN REACTION; NONHUMAN; PARASITE ISOLATION; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SKIN LEISHMANIASIS;

EID: 85030682064     PISSN: 10239510     EISSN: 20082843     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 2001; 95(3): 239-43.
2. Desjeux P. Leishmaniasis: Current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004; 27(5): 305-18.
3. Aflatoonian MR, Sharifi I. Prevalence of cutaneous leishmaniasis in Bam & Barawat, Iran. J Kerman Univ Med Sci 2006; 14(2): 82-9 [Persian].
4. Nadim A, Aflatoonian MR. Anthroponotic cutaneous leishmaniasis in the city of Bam, southeast Iran. Iranian J Pub Health 1995; 24(1-2): 15-24 [Persian].
5. Sharifi I, Zemani F, Aflatoonian MR, Fekri AR. A report of cutaneous leishmaniasis epidemic and its probable causative factors in Baft district, Kerman province. Iran J Epidemiol 2008; 4(1): 53-58 [Persian].
6. Yaghoobi-Ershadi MR, Hanafi A, Javadian E, Jafari R, Zahraei-Ramazani AR, Mohebali M. A new focus of cutaneous leishmaniasis caused by Leishmania tropica. Saudi Med J 2002; 23(3): 291-4.
7. Center for Management of Diseases, Office of Zoonotic Disease Control, Ministry of Health and Medical Education. Management of cutaneous leishmaniasis program for Bam. 2008; pp1-56 [Persian].
8. Sharifi I, Fekri A.R, Aflatoonian MR, Nadim A, Nikian Y, Khamesipour A. Cutaneous leishmaniasis in primary school children in the eastern Iranian city of Bam1994-95. Bull World Health Organ 1998; 76(3): 289-293.
9. Sharifi I, Fekri AR, Aflatoonian MR, Khamesipour A, Mabhoudi F. Leishmaniasis recidivans among school children in Bam, south-east Iran, 1994-2006. Int J Dermatol 2010; 40: 557-561.
10. Croft SL, Seifert K, Yardley V. Current scenario of drug development for leishmaniasis. Indian J Med Res 2006; 123(3): 399-410.
11. Croft SL, Sundar Sh, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microbiol Rev 2006; 19(1): 111-296.
12. Grogl M, Thomason TN, Franke ED. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am J Trop Med Hyg 1992; 47(1): 117-26.
13. Hadighi R , Mohebali M , Boucher P, Hajjaran H, Khamesipour A, Ouellette M . Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drugresistant Leishmania tropica parasites. PLoS Med 2006; 3(5): 162-8.
14. Sundar S, More DK, Singh MK, Sharma S, Makharia A, Kumar PC, et al. Failure of pentavalent antimony in visceral leishmaniasis in India. Clin Infect Dis 2000; 31(4): 1104-1107.
15. Hoffmeyer S, Burk O, Von Richter O, Arnold H .P, Brockmoller J, Johne A, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with Pglycoprotein expression and activity In vivo. Proc Natl Acad Sci U S A 2000; 97(7): 3473-8.
16. Leandro C, Campino L. Leishmaniasis: efflux pumps and chemoresistance. Int J Antimicrob Agents 2003; 22(3): 352-7.
17. Leprohon P, Legar D, Girard I, Papadoopoulou B, Ouellette M. Modulation of Leishmania ABC protein gene expression through life stages and among drug resistant parasites. Eukaryot Cell 2006; 5(10): 1713-25.
18. Perez-Victoria JM, Di Pietro A, Barron D, Ravelo AB, Castanys S, Gamarro F. Multidrug resistance phenotype mediated by the p-glycoprotein-like transporter in Leishmania. Curr Drug Targets 2002; 3(4): 311-33.
19. Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet 2005; 366(9496): 1561-77.
20. Evans DA. Leishmania. In: Taylor AER, Baker JR, (Editors). In vitro methods for parasite cultivation. London, Academic Press, 1987; PP 52-7.
21. Noyes H, Reyburn H, Bailey WJ, Smith DA. Nested-PCR based chizodem method for identifying Leishmania kinetoplast minicircle classes directly from clinical samples and its application on the study of the epidemiology of Leishmania tropica in Pakistan. J Clin Microbiol 1998; 36: 2877-4881.
22. Maraghi S, Samarbaf Zadeh A. Identification of cutaneous leishmaniasis agents by Nested-PCR in Shush city, Khozestan province, Iranian Iran. Iran J Parasitol 2007; 12(3): 13-15.
23. Nadim A, Javadian E, Mohebali M, Momeni A. Leishmania and Leishmaniasis 3rd ed., Tehran, University Center Pub, 2008; P 288.
24. Motazedian M. Study of glucantime resistance in cutaneous leishmaniasis by PCR-RFLP method in Shiraz, Iran. Abstract of European Congress of Clin Microb and Infect Dis, Prague, Czech Republic, 2004; 1-4: 86.
25. Shahbazi F. Genetic diversity of Leishmania tropica MDR1 gene in isolates in 2008-2009, city of Mashhad. PhD Dissertation in Parasitology, Shahid Baheshti University of Medical Sciences [Persian].
26. Hadighi R, Boucher P, Khamesipour A, Meamar AR, Roy G, Ouellette M, Mohebali M. Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmanisis are sensitive to alternative antileishmania drugs. Parasitol Res 2007; 101(5): 1319-22.
27. Afkar A, Sharifi I, Aflatoonian MR, Fasihi Harandi M, Fotouhi Ardakani R, Nosratabadi SJ. Epidemiological study of cutaneous leishmaniasis in Bam and Barawat during 2005 and identification of the causative species by PCR. Presented in the 6th Congress on Parasitic Diseases in Iran, Karaj, 1999 [Persian].
28. Aghasi M, Sharifi I. Survey of the fauna and monthly activity of the sandfly as the vectors of the cutaneous leishmaniasis in the city of Bam. Iranian J Med Sci 2003; 10(2): 85-91 [Persian].
29. Sharifi I, Ardehali S, Motazedian H, Aflatoonian MR, Fekri AR, Ahmadi Mousavi MR. Identification and characterization of Leishmania isolates in school children in Bam, south-eastern Iran. Iranian J Med Sci 1994; 22 (3, 4): 82-88.
30. Mahboudi F, Abolhassan M, Yaran M, Mobtaker H, Azizi M. Identification and differentiation of Iranian Leishmania species by PCR amplification of kDNA. Scand J Infect Dis 2001; 33(8): 596-8.
31. Rodriguez N, De Lima H, Aguilar EM Rodeiguez A, Barker DC, Convit J. Molecular epidemiology of cutaneous leishmaniasis in Venezuela. Trans R Soc Trop Med Hyg 2002; 96(suppll): 105-9.
32. Schonian G, Nasereddin A, Dinse N, Schweynoch C, Schallig HD, Presber W, et al. PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Infect Dis 2003; 4(1): 394-58.
33. Gangneux JP, Menotti J, Lorenzo F, Sarfati C, Blanche H, Bui H, et al. Prospective value of PCR amplification and sequencing for diagnosis and typing of old world Leishmania infections in an area of nonendemicity. J Clin Microbiol 2003; 41(4): 1419-22.